Publications en collaboration avec des chercheurs de Hospital de Cruces (9)

2014

  1. Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer

    PLoS ONE, Vol. 9, Núm. 10

2010

  1. Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma

    Tumori, Vol. 96, Núm. 3, pp. 405-410

2008

  1. Prognostic factors in cancer of unknown primary site

    Clinical and Translational Oncology

2005

  1. Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 28, Núm. 5, pp. 501-507

  2. High-dose interleukin-2 in metastatic renal cell carcinoma [3]

    Journal of Clinical Oncology

2004

  1. Factores pronósticos y predictivos en pacientes con cáncer de origen desconocido tratados con un esquema de quimioterapia con paclitaxel

    Medicina Clinica, Vol. 122, Núm. 6, pp. 216-218

2003

  1. A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer

    International Journal of Clinical Pharmacology Research, Vol. 23, Núm. 1, pp. 9-16

2002

  1. Gemcitabine and vascular toxicity [2]

    Lung Cancer

  2. Phase II study of docetaxel/vinorelbine in patients with non-small-cell-lung cancer previously treated with platinum-based chemotherapy

    Clinical Lung Cancer, Vol. 4, Núm. 3, pp. 168-173